UPDATE: Piper Sandler Assumes Biohaven Pharmaceutical Holding (BHVN) at Overweight
Tweet Send to a Friend
(Updated - October 12, 2022 8:51 AM EDT)
Piper Sandler analyst Christopher J. Raymond assumes coverage on Biohaven Pharmaceutical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Christopher J. Raymond assumes coverage on Biohaven Pharmaceutical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
